ES2111580T3 - 3-(piridinilamino)-indoles y benzo(b)tiofenos sustituidos, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

3-(piridinilamino)-indoles y benzo(b)tiofenos sustituidos, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2111580T3
ES2111580T3 ES92106162T ES92106162T ES2111580T3 ES 2111580 T3 ES2111580 T3 ES 2111580T3 ES 92106162 T ES92106162 T ES 92106162T ES 92106162 T ES92106162 T ES 92106162T ES 2111580 T3 ES2111580 T3 ES 2111580T3
Authority
ES
Spain
Prior art keywords
rent
hydrogen
aryl
alkyler
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92106162T
Other languages
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Lawrence Leo Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ES2111580T3 publication Critical patent/ES2111580T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCION ESTA RELACIONADA CON LOS COMPUESTOS CON LA FORMULA (I) EN DONDE R1 ES HIDROGENO, ALQUILO INFERIOR, ALQUENILO INFERIOR, ALQUINILO INFERIOR, ALQUILO INFERIOR DE AMINO, ALQUILO INFERIOR DE ALQUILAMINO, FORMILO, ALQUILCARBOXILO INFERIOR, ALQUILCARBOXILO INFERIOR DE AMINO O ALCOXICARBONILO INFERIOR; EL GRUPO -X-Y = ES SIENDO R2 Y R3 INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR; W ES HIDROGENO, HALOGENO, HIDROXI, ALCOXI INFERIOR, ALCOXI INFERIOR DE ARILO O EN DONDE R4 ES HIDROGENO, ALQUILO INFERIOR O ALQUILO INFERIOR DE ARILO; R5 ES ALQUILO INFERIOR O ALQUILO INFERIOR DE ARILO; O ALTERNATIVAMENTE EL GRUPO COMO UN TODO ES SIENDO R6 HIDROGENO, ALQUILO INFERIOR, ARILO O ALQUILO INFERIOR DE ARILO; Y Z ES HIDROGENO, HALOGENO, ALQUILO INFERIOR, NITRO O AMINO; QUE SON UTILES PARA ALIVIAR VARIAS DISFUNCIONES DE MEMORIA TALES COMO LA ENFERMEDAD DE ALZHEIMER, COMO MODULADORES DE FUNCIONES NEUROTRANSMISORAS TALES COMO SEROTONERGICAS Y ADRENERGICAS, Y COMO TALES SON UTILES COMO ANTIDEPRESIVOS, ANSIOLITICOS, ANTIPSICOTICOS ATIPICOS, ANTIEMETICOS, Y PARA EL TRATAMIENTO DE DESORDENES DE LA PERSONALIDAD TALES COMO DESORDENES COMPULSIVOS OBSESIVOS.
ES92106162T 1991-04-17 1992-04-09 3-(piridinilamino)-indoles y benzo(b)tiofenos sustituidos, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2111580T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/688,964 US5177088A (en) 1991-04-17 1991-04-17 Substituted 3-(pyridinylamino)-indoles

Publications (1)

Publication Number Publication Date
ES2111580T3 true ES2111580T3 (es) 1998-03-16

Family

ID=24766519

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92106162T Expired - Lifetime ES2111580T3 (es) 1991-04-17 1992-04-09 3-(piridinilamino)-indoles y benzo(b)tiofenos sustituidos, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (25)

Country Link
US (1) US5177088A (es)
EP (1) EP0509402B1 (es)
JP (1) JP2617650B2 (es)
KR (1) KR100254027B1 (es)
AT (1) ATE161840T1 (es)
AU (1) AU655253B2 (es)
BG (1) BG61034B1 (es)
CA (1) CA2066332C (es)
CS (1) CS117192A3 (es)
DE (1) DE69223837T2 (es)
DK (1) DK0509402T3 (es)
ES (1) ES2111580T3 (es)
FI (1) FI105096B (es)
GR (1) GR3026317T3 (es)
HU (1) HU215113B (es)
IE (1) IE921235A1 (es)
IL (1) IL101599A (es)
MX (1) MX9201759A (es)
NO (1) NO180486C (es)
NZ (1) NZ242359A (es)
PL (1) PL168905B1 (es)
RO (1) RO109847B1 (es)
RU (1) RU2060254C1 (es)
TW (1) TW200477B (es)
ZA (1) ZA922807B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5356910A (en) 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
ES2157442T3 (es) * 1995-06-06 2001-08-16 Aventis Pharma Inc Derivados de benzoisoxazol y de indazol, utilizados como agentes neurolepticos.
US5668154A (en) * 1995-06-06 1997-09-16 Hoechst Marion Roussel Inc. Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
DE69715668T2 (de) * 1996-12-27 2003-07-31 Aventis Pharmaceuticals Inc., Bridgewater N-(pyridinylamino)isoindoline und verwandte verbindungen
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
ATE247110T1 (de) * 1999-09-14 2003-08-15 Aventis Pharma Inc Benzisoxazolyl-, pyridoisoxazolyl- und benzthienyl-phenoxy derivate als d4 antagonisten
DE10029371A1 (de) 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
GB0217920D0 (en) * 2002-04-23 2002-09-11 Aventis Pharm Prod Inc Interleukin-4 Gene Expression inhibitors
DE602005020280D1 (de) 2004-06-01 2010-05-12 Hoffmann La Roche 3-amino-1-arylpropyl-indole als monoamin-wiederaufnahmehemmer
EP1957488B1 (en) 2005-11-30 2009-09-09 F.Hoffmann-La Roche Ag 3-amino-2-arylpropyl azaindoles and uses thereof
BRPI0619263A2 (pt) 2005-11-30 2011-09-27 Hoffmann La Roche indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis
EP2351737A1 (en) * 2005-11-30 2011-08-03 F. Hoffmann-La Roche AG 3-Amino-1-arylpropyl indoles and aza-substituted indoles
KR101098583B1 (ko) * 2008-01-04 2011-12-26 주식회사 엘지생명과학 세포, 조직 및 장기 보존 효과를 갖는 인돌 및 인다졸 유도체

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166987D1 (en) * 1980-09-18 1984-12-06 Asahi Chemical Ind 3-aminoindazole derivatives and process for preparation thereof
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4717658A (en) * 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
ES2076253T3 (es) * 1989-05-19 1995-11-01 Hoechst Roussel Pharma N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives

Also Published As

Publication number Publication date
NZ242359A (en) 1995-03-28
KR920019777A (ko) 1992-11-20
JPH05117266A (ja) 1993-05-14
HUT62572A (en) 1993-05-28
DE69223837D1 (de) 1998-02-12
JP2617650B2 (ja) 1997-06-04
AU1512192A (en) 1992-10-22
KR100254027B1 (ko) 2000-05-01
HU9201297D0 (en) 1992-07-28
EP0509402B1 (en) 1998-01-07
IL101599A0 (en) 1992-12-30
TW200477B (es) 1993-02-21
IL101599A (en) 1996-05-14
IE921235A1 (en) 1992-10-21
DE69223837T2 (de) 1998-06-25
RU2060254C1 (ru) 1996-05-20
MX9201759A (es) 1992-10-01
US5177088A (en) 1993-01-05
BG61034B1 (bg) 1996-09-30
GR3026317T3 (en) 1998-06-30
ATE161840T1 (de) 1998-01-15
FI921693A0 (fi) 1992-04-15
FI105096B (fi) 2000-06-15
PL294239A1 (en) 1993-06-14
DK0509402T3 (da) 1998-09-07
NO180486C (no) 1997-04-30
PL168905B1 (pl) 1996-05-31
ZA922807B (en) 1992-11-25
NO921505D0 (no) 1992-04-15
BG96202A (bg) 1993-12-24
FI921693A7 (fi) 1992-10-18
RO109847B1 (ro) 1995-06-30
AU655253B2 (en) 1994-12-08
NO180486B (no) 1997-01-20
NO921505L (no) 1992-10-19
CA2066332C (en) 2003-07-29
CA2066332A1 (en) 1992-10-18
EP0509402A1 (en) 1992-10-21
HU215113B (hu) 1998-12-28
CS117192A3 (en) 1992-11-18

Similar Documents

Publication Publication Date Title
MX9304996A (es) Heterociclos no-aromaticos que contienen bencilamino nitrogeno substituido.
ES2104572T3 (es) N-aminocarbamatos afines a la fisostigmina, un procedimiento para su preparacion y su uso como medicamentos.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
ECSP045229A (es) Piridinonas sustituidas como moduladores de la p38 map quinasa
ES2134926T3 (es) Derivados vinileno-azaindolicos y su procedimiento de preparacion.
ES2191005T3 (es) Taxanos sustituidos como agentes antitumorales.
UA76409C2 (uk) Трифенілалкенові похідні і їх застосування як селективних модуляторів рецепторів естрогену
ES2031841T3 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.
ES2142123T3 (es) Derivados de organosiloxanilo de alcanodiol-monovinil-eteres, proceso para su preparacion, su modificacion y su empleo como aditivos para barnices.
ES2166379T3 (es) 2-aminotetralinas sustituidas.
PE20020657A1 (es) Derivados de amida de piperidinas 1,4-disustituidas de formula (i)
ES2109239T3 (es) 5-(1-aminociclohexil)-2(1h)-piridinona y compuestos relacionados.
ES2064771T3 (es) Antagonistas de los receptores muscarinicos.
DE69120400D1 (de) Chinoxalinverbindungen, herstellung und verwendung
ES2060709T3 (es) Derivados de piridilo y pirimidilo.
ES2062758T3 (es) Nuevos analogos de vitamina d.
ES2164366T3 (es) Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.
ES2085940T3 (es) 4-amino-3-piridinoles sustituidos, un procedimiento para su preparacion y su uso como medicamentos.
ES8504805A1 (es) Un procedimiento para la preparacion de imidazobenzodiacepinas
DE69218042D1 (de) Aromatische Amid-Verbindungen und ihre Herstellung und Anwendung
MX9202736A (es) [(arilalquilpiperidin-4-il)metil)]-2a,3,4,5,-tetrahidro-1(2h)-acenafti len-1-onas y compuestos afines, un procedimiento para su preparacion y su empleo como medicamentos.
AR013152A1 (es) Derivados de 2-alquilheterodihidropirimidina, proceso para su preparacion, composiciones farmaceuticas que contienen dichos derivados y el uso de dichosderivados y composiciones como ligandos para canales de calcio neuronales de tipo n.
PT98918A (pt) Processo para a preparcao de aril-fundidas- e hetaril-fundidas-2,4-diazepinas e-2,4-diazocinas como agentes anti-arritmicos
ES2111025T3 (es) Piridinilamino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo(b)tiofenos y 1,2-benzoisotiazoles sustituidos, un procedimiento para su preparacion y su utilizacion como medicamentos.
ES2121761T3 (es) Carbamatos sustituidos de 1-(piridinilamino sustituido)-1h-indol-5-ilo, un procedimiento para su preparacion y su uso como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509402

Country of ref document: ES